Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“Happy Friday!
Can’t believe ASCO25 is only a week away! The energy is building as we gear up for one of the most important events in oncology.
I’m presenting a poster on immune expression profiles of pancreatic adenocarcinoma in the track:
Gastrointestinal Cancer-Gastroesophageal, Pancreatic, and Hepatobiliary
Saturday May 31st from 9:00 am to 12:00 CDT.I’m looking forward to an incredible lineup of pivotal trials, especially in breast cancer, that are going to be practice-changing and reconnecting with colleagues and friends across the field.
If you’ll be at ASCO25, let’s connect! Stop by our Labcorp booth 30119 or click the link below to schedule a meeting!”
